Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...

However, according to Aizer, many questions remain unanswered in the field of brain metastases, particularly concerning radiation treatment. While clinicians continually strive to improve radiation's ...

A phase III randomized trial studied the role of adjuvant WBRT in the decreased development of new CNS metastasis in melanoma. 62 Two hundred fifteen patients were randomly assigned to WBRT or ...

They are usually treated with WBRT. Patients with non–small cell lung cancer (NSCLC) are a more heterogeneous group, and 25%–40% of patients with NSCLC will develop a brain metastasis during the ...

The findings will be presented at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)• Dana-Farber ...

If WBRT is indicated, add gefitinib to the treatment regimen (level I) If gefitinib or the combination of pemetrexed and platinum compounds is indicated, add bevacizumab when not contraindicated ...

provides superior outcomes compared to hippocampal avoidance whole brain radiation therapy (HA-WBRT) in patients with 5 to 20 brain metastases. The study, which enrolled 196 patients with brain ...

Most of the new recommendations focus on the use of targeted therapy: ≥3 untreated metastases: Icotinib and whole-brain radiation therapy (WBRT) are recommended (evidence level I) Any number of ...